Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Trialssemaglutidegastric emptyinganesthesiaclinicaltrials.gov

Arkansas terminates trial of residual gastric content in GLP-1 patients

The observational study aimed to measure how often patients on GLP-1 drugs still have full stomachs after standard preoperative fasting.

PR
By Priya Raman · Science Reporter
Oct 20 08:00 ETSource: ClinicalTrials.gov

The wire

  1. 01ClinicalTrials.gov lists NCT06814080, a University of Arkansas study started 22 May 2025 on pre-op gastric emptying in GLP-1 users, as terminated.
  2. 02Aspiration risk under anesthesia in patients taking GLP-1 drugs remains an open question for perioperative teams setting fasting guidance.
  3. 03No results are posted and the registry entry gives no reason for termination, so the prevalence question the study set out to answer is unresolved.

From the source

Residual Gastric Content and GLP-1

NCT06814080 · N/A · TERMINATED · Sponsor: University of Arkansas · Conditions: Pre-op Gastric Emptying.

Read at clinicaltrials.gov
PeptiPrescribed peptides from $99/moSee all →